By Daniel Wiessner
January 5, 2026
Since the U.S. Supreme Court rolled back the constitutional right to abortion in 2022, nearly half of U.S. states have banned or severely restricted the procedure, driving a surge in medication abortion - now used in more than 60% of abortions nationwide.
That has fueled a new wave of legal battles, with Republican-led states and conservative groups pressing to curb access to the abortion drug mifepristone, while providers and Democratic-led states push to expand it. Here's a look at the key lawsuits and regulatory fights whose outcomes could impact access to the drug in the year ahead: